This spring Toronto played host to two big continuing medical education events: the CME Congress, a quadrennial meeting of the CME/continuing professional development minds; and a smaller, but very dynamic group of CME professionals worldwide who...
I’ve been thinking a lot lately about what constitutes a challenge, and why it’s important to listen when challenges come calling. I was cogitating especially heavily on the topic recently as I white-knuckled the guy-wires at the top of the SkyJ...
The long-awaited final version of the FDA’s opioid risk evaluation and mitigation strategy includes an educational “blueprint,” new opportunities for continuing medical education providers.
Massachusetts has passed revisions to its Pharmaceutical and Medical Device Manufacturer Code of Conduct that ease some of its restrictions, including the ban on providing meals at non-CME events.
The pharma company’s $3 billion settlement on improper drug promotions and misbranding charges is the largest yet for the drug industry.
Buy a tablet and toss your on-site binder, your hard-copy BEOs, your digital camera—maybe even your laptop.
